These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 12038600

  • 21. Interpretative commenting.
    Vasikaran S.
    Clin Biochem Rev; 2008 Aug; 29 Suppl 1(Suppl 1):S99-S103. PubMed ID: 18852867
    [Abstract] [Full Text] [Related]

  • 22. CEPRIME (Continuing Education and Peer Review in Internal Medicine): linking quality assurance with continuing medical education.
    Legge DG, Richmond DE.
    Aust Clin Rev; 1986 Dec; 6(23):183-9. PubMed ID: 3579727
    [Abstract] [Full Text] [Related]

  • 23. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
    Favaloro EJ, Wong RC, Silvestrini R, McEvoy R, Jovanovich S, Roberts-Thomson P.
    Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
    [Abstract] [Full Text] [Related]

  • 24. Serum vitamin A and E analysis: comparison of methods between laboratories enrolled in an external quality assurance programme.
    Greaves R, Jolly L, Woollard G, Hoad K.
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):78-80. PubMed ID: 19940209
    [Abstract] [Full Text] [Related]

  • 25. Consensus guidelines on anti-cardiolipin antibody testing and reporting.
    Wong RC, Gillis D, Adelstein S, Baumgart K, Favaloro EJ, Hendle MJ, Homes P, Pollock W, Smith S, Steele RH, Sturgess A, Wilson RJ.
    Pathology; 2004 Feb; 36(1):63-8. PubMed ID: 14757559
    [Abstract] [Full Text] [Related]

  • 26. Continuing medical education: a challenge to the Italian Scientific Societies of Laboratory Medicine.
    Plebani M.
    Clin Chim Acta; 2002 May 21; 319(2):161-7. PubMed ID: 11955494
    [Abstract] [Full Text] [Related]

  • 27. Harmonization of interpretative comments in laboratory hematology reporting: the recommendations of the Working Group on Diagnostic Hematology of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (WGDH-SIBioC).
    Buoro S, Da Rin G, Fanelli A, Lippi G.
    Clin Chem Lab Med; 2018 Dec 19; 57(1):66-77. PubMed ID: 29389663
    [Abstract] [Full Text] [Related]

  • 28. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 19; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program.
    Wong R, Wilson R, Pollock W, Steele R, Gillis D.
    Pathology; 2004 Apr 19; 36(2):174-81. PubMed ID: 15203755
    [Abstract] [Full Text] [Related]

  • 31. Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia.
    Bell DA, Bender R, Hooper AJ, McMahon J, Edwards G, van Bockxmeer FM, Watts GF, Burnett JR.
    Clin Chim Acta; 2013 Jun 25; 422():21-5. PubMed ID: 23566930
    [Abstract] [Full Text] [Related]

  • 32. Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory.
    McKenna D, Kadidlo D, Sumstad D, McCullough J.
    Cytotherapy; 2003 Jun 25; 5(4):314-22. PubMed ID: 12944238
    [Abstract] [Full Text] [Related]

  • 33. Laboratory clinical effectiveness: pathologists improving clinical outcomes.
    Schuerch C, Selna M, Jones J.
    Clin Lab Med; 2008 Jun 25; 28(2):223-44, vi. PubMed ID: 18436068
    [Abstract] [Full Text] [Related]

  • 34. Royal College of Pathologists of Australasia (RCPA) and Australasian Association of Clinical Biochemists (AACB) position statement on impaired fasting glucose.
    Royal College of Pathologists of Australasia, Australasian Association of Clinical Biochemists.
    Pathology; 2008 Oct 25; 40(6):627-8. PubMed ID: 18752132
    [No Abstract] [Full Text] [Related]

  • 35. The frequency and potential clinical impact of non-analytical errors in the RCPA Microbiology QAP 1987-2008.
    Morris AJ, Haremza E, Walker DA.
    Pathology; 2011 Jun 25; 43(4):346-9. PubMed ID: 21519289
    [Abstract] [Full Text] [Related]

  • 36. External quality assessment schemes for clinical chemistry in Germany.
    Reinauer H.
    Ann Ist Super Sanita; 1995 Jun 25; 31(1):77-86. PubMed ID: 8546378
    [Abstract] [Full Text] [Related]

  • 37. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE, Kleijnen J.
    Dtsch Med Wochenschr; 2008 Dec 25; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [Abstract] [Full Text] [Related]

  • 38. Are biochemistry interpretative comments helpful? Results of a general practitioner and nurse practitioner survey.
    Barlow IM.
    Ann Clin Biochem; 2008 Jan 25; 45(Pt 1):88-90. PubMed ID: 18275680
    [Abstract] [Full Text] [Related]

  • 39. PEIRS: a pathologist-maintained expert system for the interpretation of chemical pathology reports.
    Edwards G, Compton P, Malor R, Srinivasan A, Lazarus L.
    Pathology; 1993 Jan 25; 25(1):27-34. PubMed ID: 8316495
    [Abstract] [Full Text] [Related]

  • 40. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions.
    Nakhleh RE, Jones B, Zarbo RJ.
    Arch Pathol Lab Med; 1997 Jan 25; 121(1):11-8. PubMed ID: 9111087
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.